SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-14-050656
Filing Date
2014-02-13
Accepted
2014-02-13 14:38:01
Documents
2
Group Members
ANSBERT GADICKEJAMES PAUL SCOPALUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV4 LLCMPM ASSET MANAGEMENT INVESTORS BV5 LLCMPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KGMPM BIOVENTURES IV GP LLCMPM BIOVENTURES IV LLCMPM BIOVENTURES V GP LLCMPM BIOVENTURES V LLCM

Document Format Files

Seq Description Document Type Size
1 SC 13G d675538dsc13g.htm SC 13G 237550
2 EX-A d675538dex99a.htm EX-99.A 21360
  Complete submission text file 0001193125-14-050656.txt   260934
Mailing Address 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 617-425-9200
MPM BioVentures IV QP LP (Filed by) CIK: 0001358309 (see all company filings)

IRS No.: 204217788 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Subject) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87858 | Film No.: 14605204
SIC: 2834 Pharmaceutical Preparations